Navigation Links
Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
Date:8/12/2008

SAN DIEGO, Aug. 12 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, announced the publication of three clinical trials on the use of OraVerse (phentolamine mesylate) injection as a local dental anesthetic reversal agent in the August 2008 issue of the Journal of the American Dental Association (JADA). The first publication, entitled "Reversal of soft tissue local anesthesia with phentolamine mesylate in adolescents and adults" includes an overview of two pivotal trials while the second publication "Reversal of soft-tissue local anesthesia with phentolamine mesylate in pediatric patients" reviews the pediatric Phase 2 data. Together these key Novalar-sponsored clinical trials were the foundation for the FDA approval of OraVerse in May 2008.

"JADA's publication of these trials highlights the importance and value of these data to the dental community," commented Athena Papas, DMD, Ph.D., Professor at Tufts University School of Dental Medicine, Novalar Scientific Advisor and co-author on both publications. "Many dental patients, including children, could benefit from this clinical research which found that OraVerse helped patients regain sensation to their lips and tongue in approximately half the time following routine dental procedures."

The first publication details the efficacy and safety of OraVerse in reducing the duration of soft tissue anesthesia in patients receiving standard local anesthetic injections in two Phase 3 clinical trials. Median recovery times in the lower lip and tongue were 70 and 60 minutes compared with 155 and 125 minutes in the control group. Median recovery time in the upper lip was 50 minutes versus 133 minutes in the control. The second publication evaluated the safety of OraVerse in children aged 4 to 11 years following a dental procedure and the efficacy and safety of OraVerse to accelerate the reversal of soft-tissue local anesthesia in children aged 6 to 11 years. No serious
'/>"/>

SOURCE Novalar Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
2. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
3. Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
4. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
5. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Complete Study Results Comparing CTIs OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
8. Results Published in the Journal Cancer Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
9. Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
10. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
11. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... 20 Escalon Medical Corp...its fiscal first quarter ended September 30, 2009....duct revenue decreased approximately $234,000, or ...ended September 30, 2009 as compared to the same p...decreased net revenue of $8,434,000 compared with ...
(Date:11/20/2009)...Nov. 20 /PRNewswire-FirstCall/ -- Landauer, Inc...e fiscal fourth quarter and full year of 2009 pre-...pany will host a conference call for investors on ...me. Investors may access the live call by dialing ..., or 480-629-9835 (international callers), or by v...
(Date:11/20/2009)...ov. 20 Reportlinker.com announces ...its catalogue. ,, Pipettes & Pipettors - A...ortlinker.com/p0164373/Pipettes--Pipettors---A-Glo...amp;utm_medium=pr&utm_campaign=prnewswire ,...ral part of any research laboratory. Large-scale a...
Breaking Medicine Technology:Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 1Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 2Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 3Swedish American Life Science Summit 28SALSS 29 to Address Major Issues Including Healthcare Reform Synthetic Biology and Innovative Financing for B 13595 4Agency Provides Free Web Site Review 54652 1Agency Provides Free Web Site Review 54652 2Taking up music so you can hear 54647 1Taking up music so you can hear 54647 2Taking up music so you can hear 54647 3
(Date:11/21/2009)...Discusses Key Provisions of Legislation, Continues.... CHARLES, Ill., Nov. 21 /PRNewswire-USNewswire/ -... the landmark Affordable Health Care for America A...eform legislation forward, Congress has taken deci...system. Today, AARP hosted an educational forum t...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive game, Sp...Touch. , Mountain View, C...popular and addictive game, SplitWords, is now ava...s designed to help banish that ,tip of the tongue,...in game challenges the brain by encouraging users...
(Date:11/20/2009)...rologist Closer to Understanding Brain Wiring and ...ewswire/ -- Dr. Jeremy Schmahmann, Professor of Ne...at the Massachusetts General Hospital in Boston, o...s research on the new field of study called "Conne... ,, Dr. Schmahmann is an award-winning leader i...
(Date:11/20/2009)... Nov. 20 Following a recall by Uni...ved from sale Shedd,s Country Crock ® Side Di...try Crock ® Side Dishes DELUXE Four Cheese Pa...The following code dates and UPCs are affected: ,...XE Cheddar Broccoli Rice 21 oz, UPC 027400218316, ...
(Date:11/20/2009)...Nov. 20 Centene Corpor...present at the Bank of America Merrill Lynch 2009 ...at the Crowne Plaza Hotel Times Square in New York...ber 2nd at 8:30 a.m. Eastern Time. Investors and o...ebcast of Centene,s presentation at: http://www.v...
Breaking Medicine News(10 mins):Health News:AARP Hosts Rep. Bill Foster In Health Care Reform Forum 2Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2
...ing sponsor for the All Are Our Heroes song projec... the efforts to overcome cancer. , , ATLANTA, Apr... the science of cancer care, it,s easy to lose sig...spiring song was written to send a message of fait...
...tment will aid ,WFH,s Global Alliance for Progress...world , King of Prussia, ... In recognition of the World Federation of Hemophi...gram, CSL Behring has committed to donating to W...
...mputer technology is making it possible to view th...fore the procedure is performed – and Dr. Ti...taking advantage of it. , ...edure?’ A clear and detailed answer may have...
... -- GfK Asia is pleased to release,its first ever ...ptical,industry today in line with the 14th MAPO (...r 2009. According to our recent survey in Malaysi...e is a steady,demand for contact lenses in Malaysi...
.../ - Further to the press releases of March 31 and ...) (TSX: BLU) is pleased to announce the completion...Cdn. $20.5 million financing. , BELLUS Health rece...5 million from Victoria Square Ventures Inc.) and ...
...n as an idea to fight airborne germs and bacteria ... Accents in Water remains the only Hospital-Approv...the world today. Then, general public settings lik...manded these particular water features for their h...
Other Medicine News:Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 2Health News:Elekta Sponsors All Are Our Heroes to Raise Cancer Awareness 3Health News:CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia 2Health News:CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia 3Health News:CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia 4Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 2Health News:Nevada Breast Augmentation Surgeon Gives Reno Patients a Glimpse of Likely Results with Portrait 3D Computer Imagery 3Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 2Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 3Health News:BELLUS Health inc. announces completion of first tranche of financing 2Health News:Hospital Approved Residential Water Features Kill Harmful Airborne Bacteria 2
...ss Medical Professional Diagnostics is a leading p...nsive IFA and DFA test menu that includes kits for... as well as miscellaneous conjugates and component...ortment of substrates and kit sizes to choose from...
...ss Medical Professional Diagnostics is a leading p...nsive IFA and DFA test menu that includes kits for... as well as miscellaneous conjugates and component...ortment of substrates and kit sizes to choose from...
...adth of infectious disease ELISA products make us ...ols for faster integration into the busy laborator...ncreased reliability and run-to-run consistency. O... detection assays for a wide range of serological ...
...adth of infectious disease ELISA products make us ...ols for faster integration into the busy laborator...ncreased reliability and run-to-run consistency. O... detection assays for a wide range of serological ...
Medicine Products: